Abstract
A metabolic pathway engineered Escherichia coli strain (superbug) containing one plasmid harboring an artificial gene cluster encoding all the five enzymes in the biosynthetic pathway of Galα1,3Lac through galactose metabolism has been developed. The plasmid contains a λ promoter, a cl857 repressor gene, an ampicillin resistance gene, and a T7 terminator. Each gene was preceded by a Shine-Dalgarno sequence for ribosome binding. In a reaction catalyzed by the recombinant E. coli strain, Galα1,3Lac trisaccharide accumulated at concentrations of 14.2 mM (7.2 g L-1) in a reaction mixture containing galactose, glucose, lactose, and a catalytic amount of uridine 5′-diphosphoglucose. This work demonstrates that large-scale synthesis of complex oligosaccharides can be achieved economically and efficiently through a single, biosynthetic pathway engineered microorganism.
Original language | English (US) |
---|---|
Pages (from-to) | 47-53 |
Number of pages | 7 |
Journal | ChemBioChem |
Volume | 3 |
Issue number | 1 |
DOIs | |
State | Published - Jan 4 2002 |
Externally published | Yes |
Keywords
- Biosynthesis
- Gene expression
- Glycosylation
- Metabolic engineering
- Oligosaccharides
ASJC Scopus subject areas
- Drug Discovery
- Organic Chemistry
- Biochemistry, Genetics and Molecular Biology(all)